Rocket Pharmaceuticals, Inc.RCKTNASDAQ
LOADING
|||
Operating Income Contraction
Below historical average, strong compound growth.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-273.20M
↓ 111% below average
Average (9y)
$-129.68M
Historical baseline
Range
High:$-20.40M
Low:$-273.20M
CAGR
+33.4%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-273.20M | -5.2% |
| 2023 | $-259.66M | -15.7% |
| 2022 | $-224.34M | -34.1% |
| 2021 | $-167.25M | -23.0% |
| 2020 | $-136.00M | -78.6% |
| 2019 | $-76.15M | -7.0% |
| 2018 | $-71.16M | -166.1% |
| 2017 | $-26.74M | +36.2% |
| 2016 | $-41.88M | -105.3% |
| 2015 | $-20.40M | - |